-
Canada Approves Legal Medical Psilocybin Access For Veteran, To Undergo Apex's Macrodose Therapy (CORRECTED)
Wednesday, September 27, 2023 - 9:51am | 707Editor's note: This story has been updated to clarify that Kelsi Sheren's treatment does not represent the first legal access to medical psilocybin in Canada. Health Canada’s Special Access Program (SAP) has authorized a physician to provide Apex Labs’ psilocybin macrodose...
-
Optimi Health Will Supply Psychedelics To Canada's SAP, Secures CA$1M Private Financing
Friday, September 8, 2023 - 11:15am | 490Health Canada has approved an amendment to Optimi Health’s (OTCQX: OPTHF) dealer's license, effectively allowing the company to supply MDMA and psilocybin drugs to the country’s Special Access Program (SAP.) Since Jan. 2022 physicians have been allowed to request...
-
PharmAla Biotech Nabs First-Ever Canadian Approval To Provide MDMA Treatment Outside Clinical Setting
Thursday, May 18, 2023 - 11:36am | 323MDXX-class molecules and clinical-grade MDMA developer PharmAla Biotech and distribution partner Shaman Pharma Corp. (affiliated with GMP-compliant CCrest Labs) received Health Canada’s approval to provide proprietary LaNeo MDMA capsules to a Canadian physician for patient treatment under the...
-
Canadian Patients Demand Access To Psilocybin: Federal Lawsuit, Official Petition & Failing Mechanism
Tuesday, March 28, 2023 - 2:23pm | 587A patient-led lawsuit against the Canadian government is claiming access to therapeutic psilocybin is a constitutional right under the Canadian Charter of Rights and Freedoms. In 2020, Health Canada started granting Section 56 exemptions for psilocybin-assisted therapy under the federal...
-
MDMA News: Optimi's New Drug Now Available, Revive Advances Transdermal Patch Evaluations
Monday, February 6, 2023 - 1:09pm | 690Considering MDMA will likely be the first psychedelic to receive FDA approval for psychotherapeutic use to treat serious mental health conditions such as PTSD, several publicly listed companies are developing related products such as next-generation psychedelics- or a new delivery...
-
In Canada And In Jamaica You Can Produce Psychedelics — With Contrasting Legal Differences
Wednesday, January 11, 2023 - 5:50pm | 711Red Light Holland Moves Full Speed Towards Canadian Controlled Drugs and Substances Dealer's License Ontario-based magic mushrooms producer Red Light Holland Corp. (OTCQB: TRUFF) hired compliance consultants Cannabis License Experts Inc (CLE) to assist with an application for a Controlled Drugs...
-
Canada: Fed Guidelines For Psychedelic Therapy, Quebec Treatment Costs, Access And Magic Mushrooms Dispensaries
Wednesday, December 21, 2022 - 6:41pm | 1111The agency regulating all things related to psychedelic-assisted therapy (PAT), Health Canada released a notice to stakeholders on risk-management measures for clinical trials, a seemingly supporting move towards future government-supported access. As stated, the purpose of notice 22-...
-
Psychedelics Developer & Mass-Scale Manufacturer Will Deliver Novel Magic Mushroom Products
Monday, September 26, 2022 - 3:41pm | 344Life sciences biotech company Core One Labs Inc. (OTCQB: CLABF) signed a Letter of Intent with GMP-certified manufacturer Medelys Laboratories International Inc. for the manufacturing of its proprietary psychedelic active pharmaceutical ingredient (API) products. Core One’s subsidiary Vocan...
-
Ketamine Therapy Growing In US And Canada With This Novel Montreal Clinic
Thursday, September 22, 2022 - 3:52pm | 575Legal ketamine-assisted therapy for people with diagnosed mental health conditions continues to expand throughout the U.S. and Canada. Numinus Wellness Inc. (OTCQX: NUMIF) announced the opening of a second Canada-based clinic in a week offering several therapy modalities for the...
-
Toronto Residents Get New Ketamine-Assisted Therapy Option Close To Home
Monday, September 19, 2022 - 1:20pm | 415The Neurology Centre of Toronto (NCT), located in a midtown neighborhood and owned by Numinus Wellness Inc. (OTCQX: NUMIF), is offering ketamine-assisted therapy for patients with neurologic conditions diagnoses. Numinus is focused on delivering evidence-based, innovative and safe...
-
What A Collab! Optimi Health & Patient Advocate Thomas Hartle's New Medical Psilocybin Venture
Monday, August 8, 2022 - 2:11pm | 588Optimi Health Corp. (OTCQX: OPTHF), the Canadian licensed psychedelic and functional mushrooms producer has signed a partnership agreement with psilocybin patient advocate Thomas Hartle to produce a novel homegrown, natural therapeutic psilocybin product for approved patients. Who Is Thomas...
-
HAVN Life Sciences & Optimi Health Corp Announce Supply Agreements, Here Are The Details
Tuesday, June 28, 2022 - 3:29pm | 516Two publicly traded psychedelics companies announced supply agreements. HAVN Life Sciences (OTC: HAVLF) will provide mental health clinic MPB Group Inc. with psilocybin-containing mushrooms for its therapeutic retreats in Jamaica and Optimi Health Corp. (OTCQX: OPTHF) will supply...
-
Canadian Special Access Program Further Authorizes Novel Psychedelic Drugs For Emergency Treatments
Thursday, June 16, 2022 - 3:20pm | 576For those unaware, Canada provides a legal way for patients presenting unresolved mental health issues to receive psychedelic-assisted treatment. While the country still has not provided legal status to psychedelics, recent amendments have made it possible for health practitioners to request...
-
Braxia Opens New Clinic in Ontario, Facilitating Further Access To Ketamine And Psilocybin Treatments
Wednesday, June 15, 2022 - 4:10pm | 436Braxia Scientific Corp. (CSE: BRAX) (OTC: BRAXF), a medical research company with clinics that provide innovative treatments for people suffering from major depressive disorder and related mental health conditions, has opened a new health clinic in the Kitchener-Waterloo area in Ontario, CA, which...